Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year result...

por Hirsch, I. B., Franek, E., Mersebach, H., Bardtrum, L., Hermansen, K.
Publicado 2016

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

por Ratner, R E, Gough, S C L, Mathieu, C, Del Prato, S, Bode, B, Mersebach, H, Endahl, L, Zinman, B
Publicado 2013